273 related articles for article (PubMed ID: 32676896)
1. Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy.
Lee M; Suzuki H; Kato R; Fukao Y; Nakayama M; Kano T; Makita Y; Suzuki Y
CEN Case Rep; 2021 Feb; 10(1):17-22. PubMed ID: 32676896
[TBL] [Abstract][Full Text] [Related]
2. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
Zhao L; Peng L; Yang D; Chen S; Lan Z; Zhu X; Yuan S; Chen G; Liu Y; Liu H
Clin Immunol; 2020 Aug; 217():108483. PubMed ID: 32479989
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy.
Zhang K; Li Q; Zhang Y; Shang W; Wei L; Li H; Gao S; Yan T; Jia J; Liu Y; Lin S
Kidney Blood Press Res; 2019; 44(5):1196-1206. PubMed ID: 31574506
[TBL] [Abstract][Full Text] [Related]
4. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
Suzuki H; Yasutake J; Makita Y; Tanbo Y; Yamasaki K; Sofue T; Kano T; Suzuki Y
Kidney Int; 2018 Mar; 93(3):700-705. PubMed ID: 29329643
[TBL] [Abstract][Full Text] [Related]
5. Galactose-Deficient IgA1-Specific Antibody Recognizes GalNAc-Modified Unique Epitope on Hinge Region of IgA1.
Yamasaki K; Suzuki H; Yasutake J; Yamazaki Y; Suzuki Y
Monoclon Antib Immunodiagn Immunother; 2018 Dec; 37(6):252-256. PubMed ID: 30570353
[TBL] [Abstract][Full Text] [Related]
6. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
[TBL] [Abstract][Full Text] [Related]
7. Immunostaining for galactose-deficient immunoglobulin A is not specific for primary immunoglobulin A nephropathy.
Cassol CA; Bott C; Nadasdy GM; Alberton V; Malvar A; Nagaraja HN; Nadasdy T; Rovin BH; Satoskar AA
Nephrol Dial Transplant; 2020 Dec; 35(12):2123-2129. PubMed ID: 31369128
[TBL] [Abstract][Full Text] [Related]
8. Glomerular Galactose-Deficient IgA1(KM55) Positive May Predict Poorer Prognosis in Coexisting Primary Membranous Nephropathy and IgA Nephropathy Patients.
Cheng W; Wang G; Guo W; Sun L; Xu X; Dong H; Ye S; Geng Y; Cheng H
Cells; 2022 Dec; 12(1):. PubMed ID: 36611910
[TBL] [Abstract][Full Text] [Related]
9. Crescentic IgA nephropathy after administration of human monoclonal interleukin-12/23p40 antibody in a patient with Crohn's disease: a case report.
Kanazawa N; Wada Y; Akiyama M; Shikida Y; Sugiyama M; Abe M; Iyoda M; Honda K; Shibata T
CEN Case Rep; 2020 Aug; 9(3):204-209. PubMed ID: 32100251
[TBL] [Abstract][Full Text] [Related]
10. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.
Yasutake J; Suzuki Y; Suzuki H; Hiura N; Yanagawa H; Makita Y; Kaneko E; Tomino Y
Nephrol Dial Transplant; 2015 Aug; 30(8):1315-21. PubMed ID: 26109484
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
Wada Y; Matsumoto K; Suzuki T; Saito T; Kanazawa N; Tachibana S; Iseri K; Sugiyama M; Iyoda M; Shibata T
PLoS One; 2018; 13(11):e0206865. PubMed ID: 30388165
[TBL] [Abstract][Full Text] [Related]
12. Glomerular galactose-deficient IgA1 expression analysis in pediatric patients with glomerular diseases.
Ishiko S; Horinouchi T; Fujimaru R; Shima Y; Kaito H; Tanaka R; Ishimori S; Kondo A; Nagai S; Aoto Y; Sakakibara N; Nagano C; Yamamura T; Yoshimura M; Nakanishi K; Fujimura J; Kamiyoshi N; Nagase H; Yoshikawa N; Iijima K; Nozu K
Sci Rep; 2020 Aug; 10(1):14026. PubMed ID: 32820208
[TBL] [Abstract][Full Text] [Related]
13. Primary IgA Vasculitis with Nephritis in a Patient with Rheumatoid Arthritis Diagnosed by Anti-galactose-deficient IgA1 Immunostaining.
Karasawa K; Iwabuchi Y; Kyoda M; Akihisa T; Yamaguchi E; Suzuki S; Ogura S; Takabe T; Miyabe Y; Kamiyama T; Nakano M; Manabe S; Kamiyama M; Akiyama K; Sato M; Uchida K; Nitta K; Moriyama T
Intern Med; 2019 Sep; 58(17):2551-2554. PubMed ID: 31178497
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy.
Irabu H; Shimizu M; Kaneko S; Inoue N; Mizuta M; Ohta K; Yachie A
J Immunol Res; 2020; 2020():4284379. PubMed ID: 32537466
[TBL] [Abstract][Full Text] [Related]
15. KM55 Monoclonal Antibody Staining in IgA-Dominant Infection-Related Glomerulonephritis.
Zhang M; Zhou W; Liu S; Zhang L; Ni Z; Hao C
Nephron; 2021; 145(3):225-237. PubMed ID: 33596564
[TBL] [Abstract][Full Text] [Related]
16. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
Martín-Penagos L; Fernández-Fresnedo G; Benito-Hernández A; Mazón J; de Cos M; Oviedo MV; San Segundo D; López-Hoyos M; Gómez-Román J; Ruiz JC; Rodrigo E
Nefrologia (Engl Ed); 2021; 41(3):311-320. PubMed ID: 33741175
[TBL] [Abstract][Full Text] [Related]
17. Crohn's disease may promote inflammation in IgA nephropathy: a case-control study of patients undergoing kidney biopsy.
Akiyama M; Shimomura K; Yoshimoto H; Sako M; Kodama M; Abe K; Gunji M; Kang D; Takaki T; Wada Y; Iyoda M; Honda K
Virchows Arch; 2022 Oct; 481(4):553-563. PubMed ID: 35809093
[TBL] [Abstract][Full Text] [Related]
18. Utility of glomerular Gd-IgA1 staining for indistinguishable cases of IgA nephropathy or Alport syndrome.
Ishiko S; Tanaka A; Takeda A; Hara M; Hamano N; Koizumi M; Ueno T; Hayashi H; Kondo A; Nagai S; Aoto Y; Sakakibara N; Nagano C; Horinouchi T; Yamamura T; Ninchoji T; Shima Y; Nakanishi K; Yoshikawa N; Iijima K; Nozu K
Clin Exp Nephrol; 2021 Jul; 25(7):779-787. PubMed ID: 33743099
[TBL] [Abstract][Full Text] [Related]
19. The significance of galactose-deficient immunoglobulin A1 staining in kidney diseases with IgA deposition.
Tang X; Zheng J; Jiang X; Wan F; Hou X; Liu S; Zhang M; Song Y; Ye T; Yu J
Int Urol Nephrol; 2023 Aug; 55(8):2119-2129. PubMed ID: 36849627
[TBL] [Abstract][Full Text] [Related]
20. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
Martín-Penagos L; Fernández-Fresnedo G; Benito-Hernández A; Mazón J; de Cos M; Oviedo MV; San Segundo D; López-Hoyos M; Gómez-Román J; Ruiz JC; Rodrigo E
Nefrologia (Engl Ed); 2021; 41(3):311-320. PubMed ID: 36166247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
